A new noninvasive alternative to colonoscopies is as easy as swallowing a pill.
The patient ingests PillCam™ Colon 2, a capsule containing two miniature cameras on either end. As the capsule travels through the digestive tract, it captures images and wirelessly transmits them to a recorder the patient wears on a belt.
Loyola Medicine’s digestive health program is the first in the Chicago area to offer this latest alternative to colonoscopy. Like a colonoscopy, the system can help identify growths called polyps.
During a standard colonoscopy, a flexible tube (colonoscope) is inserted into the rectum and guided by a physician through the colon. A camera at the end of the colonoscope allows for visualization of polyps which, if left in place, can turn into cancer. The polyps are removed during the procedure. Patients are sedated and need to take a day off from their usual activities.
Colonoscopies are safe and have been proven to be an effective way to screen for colon cancer. However, some patients cannot tolerate the procedure, or may be at higher risk for sedation.
With the new system, the patient swallows the capsule with water. After the non-reusable capsule is excreted, it’s flushed down the toilet. The patient returns the recorder to the physician’s office. If a polyp is found, the patient arranges to undergo a colonoscopy to remove the growth.
Colorectal cancer is the third-leading cause of cancer deaths in women and second leading cause in men. Early detection and screening are essential to reduce the rates of colorectal cancer.
“The video capsule system is the only alternative screening method for colon cancer that allows for direct visualization of colon polyps,” said Mukund Venu, MD, director of clinical operations and director of diagnostic testing for Loyola Medicine’s division of gastroenterology. “Early detection has been proven to save lives, and the video capsule system offers a convenient screening test for people who are unable to have a complete colonoscopy.”
Dr. Venu, who has subspecialty training in capsule endoscopy, will perform the test.
A patient who undergoes the capsule technique must do the same bowl-cleansing preparation as a patient undergoing a colonoscopy. But unlike a standard colonoscopy, the pill capsule system is painless and requires no anesthesia. Patients do not have to take a day off work or arrange for someone to drive them to and from the test.
The U.S. Food and Drug Administration has approved the capsule system for patients who are not candidates for colonoscopies for one of two reasons:
– The anatomy of the colon makes it difficult to guide a colonoscope through the entire colon
– The patient experiences lower gastrointestinal bleeding but is not suitable for a colonoscopy because of an elevated risk of complications due to age or other reasons
Loyola is participating in a multicenter clinical trial to determine whether the capsule system is safe and effective for a broader population of patients who could tolerate a colonoscopy but would prefer to swallow a capsule.
[osd_subscribe categories=’diagnostic tool’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “DIAGNOSTIC TOOL”‘]
Receive an email update when we add a new DIAGNOSTIC TOOL article.
The Latest on: PillCam
[google_news title=”” keyword=”PillCam” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: PillCam
- What's in the Cards for Medtronic (MDT) in Q2 Earnings?on November 17, 2023 at 8:28 am
Medtronic plc MDT is scheduled to report second-quarter fiscal 2023 results on Nov 21, before the opening bell. In the last reported quarter, the company’s earnings exceeded the Zacks Consensus ...
- Enterobius vermicularis, the small human pinworm: a chronic infestation diagnosed by Pillcam. Incidental observation on Capsule Endoscopyon November 6, 2023 at 11:54 pm
We will not keep your email address; we ask for it so your friend knows the email isn't spam.
- The Race for Mainstream Gastrointestinal Endoscopy: Frontrunnerson September 28, 2023 at 5:00 pm
CCE PillCam® (Given Imaging) is a new, not yet fully established noninvasive method of examining the entire colon (Figure 2). Only a few comparative studies between CCE and colonoscopy have been ...
- PillCam ® WCE is a feasible colorectal screening strategy for selected patientson June 18, 2021 at 11:34 am
Eliakim and colleagues' prospective, multicenter, proof-of-concept study compared WCE using the PillCam ® Colon capsule (Given Imaging Ltd, Yoqneam, Israel) with conventional colonoscopy ...
- PTH-031 Pillcam sb2 and sb3 small bowel capsule endoscopy – comparisons and implications for practiceon October 30, 2019 at 10:02 pm
We have previously shown that the diagnostic yield (DY) of the PillCam SB3 capsule (Given Imaging, Israel) is significantly higher than that of the PillCam SB2. 1 Here we present additional data on ...
- PillCam: Hampstead’s Royal Free Hospital pilots pill-sized bowel camera that ‘could make endoscopies a thing of the past’on March 27, 2019 at 12:00 am
A pill that takes photos inside patients’ bowels at the Royal Free to screen for cancer could make endoscopies a thing of the past, bosses say. The “PillCam” contains a camera at either end ...
- PTH-022 A Novel Experience of The Pillcam® ESO 3 Capsule Endoscope In Patients Unwilling To Undergo Conventional Upper GI Endoscopyon September 7, 2018 at 5:56 pm
Introduction Gastroscopy (OGD) is the gold standard test for investigating dyspepsia, but is uncomfortable, incurs the risk of intubation and sedation and has a diagnostic yield in our practice in ...
- Gastrointestinal Complications of Dual Antiplatelet Therapyon March 27, 2006 at 4:00 pm
The higher the overall score, the more severe are the symptoms. A noninvasive imaging test that does not require sedation to diagnose occult GI complications is the PillCam ESO capsule endoscopy ...
via Bing News